View source for Nitroglycerin (Topical ointment)

{{DrugProjectFormSinglePage
|offLabelAdultGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of Nitroglycerin (Topical ointment) in adult patients.
|offLabelAdultNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of Nitroglycerin (Topical ointment) in adult patients.
|offLabelPedGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of Nitroglycerin (Topical ointment) in pediatric patients.
|offLabelPedNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of Nitroglycerin (Topical ointment) in pediatric patients.
|clinicalTrials=There is limited information regarding <i>Clinical Trials Experience</i> of Nitroglycerin (Topical ointment) in the drug label.
|postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of Nitroglycerin (Topical ointment) in the drug label.
|useInLaborDelivery=There is no FDA guidance on the use of Nitroglycerin (Topical ointment) during labor and delivery.
|useInNursing=There is no FDA guidance on the use of Nitroglycerin (Topical ointment) with respect to nursing mothers.
|useInPed=There is no FDA guidance on the use of Nitroglycerin (Topical ointment) with respect to pediatric patients.
|useInGeri=There is no FDA guidance on the use of Nitroglycerin (Topical ointment) with respect to geriatric patients.
|useInGender=There is no FDA guidance on the use of Nitroglycerin (Topical ointment) with respect to specific gender populations.
|useInRace=There is no FDA guidance on the use of Nitroglycerin (Topical ointment) with respect to specific racial populations.
|useInRenalImpair=There is no FDA guidance on the use of Nitroglycerin (Topical ointment) in patients with renal impairment.
|useInHepaticImpair=There is no FDA guidance on the use of Nitroglycerin (Topical ointment) in patients with hepatic impairment.
|useInReproPotential=There is no FDA guidance on the use of Nitroglycerin (Topical ointment) in women of reproductive potentials and males.
|useInImmunocomp=There is no FDA guidance on the use of Nitroglycerin (Topical ointment) in patients who are immunocompromised.
|monitoring=There is limited information regarding <i>Monitoring</i> of Nitroglycerin (Topical ointment) in the drug label.
|PD=There is limited information regarding <i>Pharmacodynamics</i> of Nitroglycerin (Topical ointment) in the drug label.
|PK=There is limited information regarding <i>Pharmacokinetics</i> of Nitroglycerin (Topical ointment) in the drug label.
|nonClinToxic=There is limited information regarding <i>Nonclinical Toxicology</i> of Nitroglycerin (Topical ointment) in the drug label.
|clinicalStudies=There is limited information regarding <i>Clinical Studies</i> of Nitroglycerin (Topical ointment) in the drug label.
|fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of Nitroglycerin (Topical ointment) in the drug label.
|alcohol=Alcohol-Nitroglycerin (Topical ointment) interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
|brandNames=®
|lookAlike=A® — B®
}}